A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)
Condition(s):Chronic Idiopathic UrticariaLast Updated:July 11, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Idiopathic UrticariaLast Updated:July 11, 2017Completed
Condition(s):Post Operative Nausea and Vomiting; Rescue Emetic TherapyLast Updated:November 14, 2017Withdrawn
Condition(s):Chronic Hepatitis BLast Updated:December 5, 2017Terminated
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 1, 2017Terminated
Condition(s):Asymptomatic HyperuricemiaLast Updated:December 27, 2023Completed
Condition(s):FibrosisLast Updated:January 12, 2018Completed
Condition(s):Migraine; Migraine in ChildrenLast Updated:December 26, 2023Recruiting
Condition(s):Polybrominated Biphenyl PoisoningLast Updated:March 15, 2024Completed
Condition(s):Environmental-Pollution-Related ConditionLast Updated:August 4, 2023Completed
Condition(s):Follicular LymphomaLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.